MFN2 Gene CMT2A2 Genetic Test
At DNA Labs UAE, we offer the MFN2 Gene CMT2A2 Genetic Test for individuals suspected of having Charcot-Marie-Tooth disease type 2A2 (CMT2A2). This hereditary neurological disorder affects the peripheral nerves and is characterized by muscle weakness and wasting, particularly in the feet and lower legs, as well as sensory loss in the affected areas.
Test Details
The MFN2 gene is associated with CMT2A2. Our NGS (next-generation sequencing) technology allows us to analyze the MFN2 gene for mutations that may cause CMT2A2. This comprehensive genetic testing method can detect a wide range of genetic variations in a single test, making it an invaluable tool for diagnosing and managing genetic disorders.
Test Components and Price
- Components: Blood or Extracted DNA or One drop Blood on FTA Card
- Price: 4400.0 AED
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on an FTA Card for this test.
Report Delivery
After the sample is received, the test results will be delivered within 3 to 4 weeks.
Test Type
This test falls under the category of Neurological Disorders.
Doctor and Test Department
This test is conducted by our experienced neurologists in our Genetics department.
Pre Test Information
Prior to undergoing the MFN2 Gene CMT2A2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with MFN2 Gene CMT2A2.
Treatment and Management
If a mutation is identified in the MFN2 gene, genetic counseling may be recommended to discuss the implications of the test results and provide guidance on managing the condition. Treatment for CMT2A2 may include physical therapy, orthotics, and other supportive measures to manage symptoms and improve quality of life.
Test Name | MFN2 Gene CMT2A2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MFN2 Gene CMT2A2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MFN2 Gene CMT2A2 |
Test Details | The MFN2 gene is associated with Charcot-Marie-Tooth disease type 2A2 (CMT2A2), which is a hereditary neurological disorder affecting the peripheral nerves. CMT2A2 is characterized by muscle weakness and wasting, particularly in the feet and lower legs, as well as sensory loss in the affected areas. NGS (next-generation sequencing) genetic testing can be used to analyze the MFN2 gene for mutations that may cause CMT2A2. This type of testing is able to detect a wide range of genetic variations in a single test, making it a valuable tool for diagnosing and managing genetic disorders. If a mutation is identified in the MFN2 gene, genetic counseling may be recommended to discuss the implications of the test results and to provide guidance on managing the condition. Treatment for CMT2A2 may include physical therapy, orthotics, and other supportive measures to manage symptoms and improve quality of life. |